|
Volumn 26, Issue 4, 2015, Pages 31-34
|
Polypharmacy - appropriate, problematic or both?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALENDRONIC ACID;
AMLODIPINE;
ANTIBIOTIC AGENT;
ATORVASTATIN;
BISPHOSPHONIC ACID DERIVATIVE;
CALCIUM;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
GINKGO BILOBA EXTRACT;
IBUPROFEN;
NAPROXEN;
NONSTEROID ANTIINFLAMMATORY AGENT;
OMEPRAZOLE;
PARACETAMOL;
RAMIPRIL;
SALBUTAMOL;
SIMVASTATIN;
VITAMIN D;
ALCOHOL CONSUMPTION;
ANKLE EDEMA;
APPROPRIATE POLYPHARMACY;
ARTICLE;
BRONCHITIS;
CARDIOVASCULAR DISEASE;
CAUSE OF DEATH;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLOSTRIDIUM DIFFICILE INFECTION;
CONFUSION;
DISEASE COURSE;
DRUG CONTRAINDICATION;
DRUG DOSE REDUCTION;
DRUG INDICATION;
DRUG INFORMATION;
DRUG SAFETY;
DYSPEPSIA;
DYSPNEA;
EVENING DOSAGE;
EVIDENCE BASED MEDICINE;
GASTROINTESTINAL HEMORRHAGE;
HEALTH CARE NEED;
HEALTH CARE SYSTEM;
HUMAN;
HYPERTENSION;
LIFE EXPECTANCY;
MEDICAL EDUCATION;
MEDICAL RESEARCH;
MOOD;
MORBIDITY;
NUMBERS NEEDED TO HARM;
NUMBERS NEEDED TO TREAT;
OSTEOARTHRITIS;
PALLIATIVE THERAPY;
PHARMACEUTICAL CARE;
POLYPHARMACY;
PRACTICE GUIDELINE;
PRESCRIPTION;
PROBLEMATIC POLYPHARMACY;
QUALITY OF LIFE;
RELIABILITY;
SMOKING;
SMOKING CESSATION;
SPIROMETRY;
STATISTICAL ANALYSIS;
TERMINAL CARE;
TREATMENT OUTCOME;
UNITED KINGDOM;
|
EID: 85009699661
PISSN: 09596682
EISSN: 19312253
Source Type: Journal
DOI: 10.1002/psb.1313 Document Type: Article |
Times cited : (2)
|
References (7)
|